Media Mentions
2008
Arnold Friede, Elizabeth Hack, Robert Nicholas, Paul Radensky and T. Reed Stephens were mentioned in a May 29 article in FDA Webview regarding the recent White Paper they had authored regarding Merck’s $58 million settlement of consumer fraud claims by state attorneys general.
Arnold I. Friede, Elizabeth I. Hack, Robert B. Nicholas, Paul W. Radensky M.D., T. Reed Stephens, Health, Life Sciences - Health
Elizabeth I. Hack was quoted in the January 24 issue of Rx Compliance Report in an article regarding 2008 being a record year for pharma fraud recoveries along with surge in state, global and Part D enforcement. "Another important signal is that the AWP matters brought by the state are continuing to move forward at a faster pace than the Multi-District Litigation (MDL) in Boston. This is evidenced by the fact that next month Alabama will be the first state to bring to trial the state consumer fraud theories relating to AWP drug pricing," Ms. Hack said.
Elizabeth I. Hack, Health, Life Sciences & Medical Devices, Life Sciences - Health
2007
Elizabeth I. Hack and T. Reed Stephens were both quoted in the January 16 issue of Rx Compliance Report. In regards to reviews of state False Claims Act statues, Mr. Stephens said, "State Attorney General offices are poised to continue their track record of successful enforcement against the industry. California and Texas will likely be in the forefront despite the negative view of their False Claims Act statutes rendered by the OIG." Ms. Hack was mentioned in regards to the average wholesale price drug pricing matters. "In the coming year, the Department of Justice will pursue the remaining handful of manufacturers named qui tam complaint. Plaintiffs' firms will continue to sign up states to pursue AWP matters in hopes that the sheer number of state lawsuits will force the manufacturers to the settlement table," she said. The article also highlighted Ms. Hack and Mr. Stephens' recent move to McDermott.
